Buy Day today: Good (67) Broad market participation · no major macro event

Fortress Biotech Inc (FBIO)

Healthcare Biotechnology

2.80 $

-11.8% vs. previous close

Closing price · As of: 3. Aug 2026

Fortress Biotech Inc (FBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 357 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow

Annual Quarterly

All figures in millions of USD.

Balance Sheet FBIO
Tick rows to compare them in a chart (up to 4)	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26
Total Assets	181	151	168	165	146	127	144	178	160	181	186	357
Current Assets	128	98	117	117	103	86	90	127	110	119	124	295
Cash	87	75	81	86	76	59	57	91	74	86	79	256
Cash & Short-Term Investments	87	75	81	86	76	59	57	91	74	86	79	256
Receivables	17	8.2	15	10	11	11	10	18	16	18	30	26
Inventory	12	11	10	11	9.7	12	14	12	13	12	9.6	9.3
Property, Plant & Equipment	7.2	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	22	21	20	19	19	18	32	31	30	29	28	26
Total Liabilities	197	164	166	169	160	140	146	146	123	116	123	155
Current Liabilities	129	97	85	88	76	70	71	74	58	54	50	103
Short-Term Debt	18	9.2	5.5	9.6	5.5	3.8	3.2	4.0	5.9	7.8	2.1	4.7
Accounts Payable	49	45	35	42	38	34	32	28	20	19	14	14
Long-Term Debt	47	46	61	61	67	52	58	56	50	48	60	37
Shareholders' Equity	19	17	23	23	18	21	23	22	44	56	50	162
Retained Earnings	-681	-686	-695	-710	-721	-734	-741	-751	-736	-730	-734	-624
Shares Outstanding	7.4	7.5	7.8	17	18	20	20	26	30	33	279	38

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Cookie settings